IP 179 (Metformin ER 750 mg)

Pill imprint IP 179 has been identified as Metformin hydrochloride extended release 750 mg.

Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 750 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for IP 179

Metformin hydrochloride extended release 750 mg IP 179
Metformin hydrochloride extended release 750 mg IP 179
Metformin hydrochloride extended release
Imprint:
IP 179
Strength:
750 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Non-sulfonylureas
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Amneal Pharmaceuticals
National Drug Code (NDC):
53746-0179
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-6108 Major Pharmaceuticals
65162-0179 Amneal Pharmaceuticals
42291-0611 AvKare Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)